Literature DB >> 19199029

Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis.

Fabio Di Domenico1, Fabio D Domenico, Giovanna Cenini, Rukhsana Sultana, Marzia Perluigi, Daniela Uberti, Maurizio Memo, D Allan Butterfield.   

Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disorder. The exact mechanism for the AD pathogenesis is not clearly understood. However, a number of hypotheses have been proposed to explain the pathogenesis of AD. One the hypotheses is the oxidative stress hypothesis that is supported by a number of studies which reported an increase in the levels of reactive oxygen/reactive nitrogen species and their products with a concomitant decrease in the levels of antioxidant enzymes in AD brain. In the present study, we measured in AD brain the expression levels of different forms (monomer, dimer and tetramer) of the pro-apoptotic protein, p53, and observed greater levels of p53 monomer and dimer in AD brain compared to control. In addition, we also showed the selective glutathionylation of monomeric and dimeric form of p53 in AD brain. We propose that glutathionylation of p53 may prevent the formation of tetramer, an aggregate form required for effective action of p53, and may be involved in oxidative stress conditions and neurodegeneration observed in this dementing disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199029      PMCID: PMC2810644          DOI: 10.1007/s11064-009-9924-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  55 in total

1.  Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease.

Authors:  M Y Aksenov; W R Markesbery
Journal:  Neurosci Lett       Date:  2001-04-20       Impact factor: 3.046

Review 2.  Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress.

Authors:  P Klatt; S Lamas
Journal:  Eur J Biochem       Date:  2000-08

Review 3.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

Authors:  F Q Schafer; G R Buettner
Journal:  Free Radic Biol Med       Date:  2001-06-01       Impact factor: 7.376

Review 4.  Glutathione, oxidative stress and neurodegeneration.

Authors:  J B Schulz; J Lindenau; J Seyfried; J Dichgans
Journal:  Eur J Biochem       Date:  2000-08

Review 5.  Structural, redox, and mechanistic parameters for cysteine-sulfenic acid function in catalysis and regulation.

Authors:  A Claiborne; T C Mallett; J I Yeh; J Luba; D Parsonage
Journal:  Adv Protein Chem       Date:  2001

6.  p53 protein oxidation in cultured cells in response to pyrrolidine dithiocarbamate: a novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genes.

Authors:  H H Wu; J A Thomas; J Momand
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

7.  Acute cadmium exposure inactivates thioltransferase (Glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis.

Authors:  C A Chrestensen; D W Starke; J J Mieyal
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

8.  Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.

Authors:  Rukhsana Sultana; Debra Boyd-Kimball; H Fai Poon; Jian Cai; William M Pierce; Jon B Klein; Michael Merchant; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Aging       Date:  2005-11-04       Impact factor: 4.673

9.  The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

Authors:  C M Lauderback; J M Hackett; F F Huang; J N Keller; L I Szweda; W R Markesbery; D A Butterfield
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

Review 10.  Glutathione and its role in cellular functions.

Authors:  H Sies
Journal:  Free Radic Biol Med       Date:  1999-11       Impact factor: 7.376

View more
  31 in total

1.  Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysis.

Authors:  Cheng Zhang; Ching-Chang Kuo; Alan W L Chiu; June Feng
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

3.  Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model.

Authors:  Cheng Zhang; Ching-Chang Kuo; Setareh H Moghadam; Louise Monte; Kenner C Rice; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 4.  Elevation of glutathione as a therapeutic strategy in Alzheimer disease.

Authors:  Chava B Pocernich; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2011-10-12

Review 5.  Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System.

Authors:  Xiaoyuan Ren; Lili Zou; Xu Zhang; Vasco Branco; Jun Wang; Cristina Carvalho; Arne Holmgren; Jun Lu
Journal:  Antioxid Redox Signal       Date:  2017-05-18       Impact factor: 8.401

Review 6.  S-glutathionylation: from molecular mechanisms to health outcomes.

Authors:  Ying Xiong; Joachim D Uys; Kenneth D Tew; Danyelle M Townsend
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

Review 7.  The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease.

Authors:  Ryan R Dyer; Katarena I Ford; Renã A S Robinson
Journal:  Methods Enzymol       Date:  2019       Impact factor: 1.600

Review 8.  Reversible and irreversible protein glutathionylation: biological and clinical aspects.

Authors:  Arthur Jl Cooper; John T Pinto; Patrick S Callery
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-05-11       Impact factor: 4.481

Review 9.  Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.

Authors:  Liqing Gu; Renã A S Robinson
Journal:  Proteomics Clin Appl       Date:  2016-11-11       Impact factor: 3.494

Review 10.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.